The trading price of Boston Scientific Corp. (NYSE:BSX) floating higher at last check on Monday, April 22, closing at $67.90, 0.85% higher than its previous close.
The company’s P/E ratio in the trailing 12-month period was 63.44. In examining the 52-week price action we see that the stock hit a 52-week high of $69.21 and a 52-week low of $48.35. Over the past month, the stock has gained 0.51% in value.
Boston Scientific Corp., whose market valuation is $99.81 billion at the time of this writing. Investors’ optimism about the company’s current quarter earnings report is understandable.
A company’s earnings reviews provide a brief indication of a stock’s direction in the short term, where in the case of Boston Scientific Corp. No upward and no downward comments were posted in the last 7 days. On the technical side, indicators suggest BSX has a 50% Buy on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 100% Buy, while an average of long term indicators suggests that the stock is currently 100% Buy.
If we dig deeper into the stock’s outlook, we see that the stock’s PEG is 5.17, which symbolizes a positive outlook. A quick review shows that BSX’s price is currently -0.22% off the SMA20 and 1.09% off the SMA50. The RSI metric on the 14-day chart is currently showing 52.19, and weekly volatility stands at 1.75%. When measured over the past 30 days, the indicator reaches 1.34%. Boston Scientific Corp. (NYSE:BSX)’s beta value is currently sitting at 0.78, while the Average True Range indicator is currently displaying 1.01.
To see how Boston Scientific Corp. stock has been performing today in comparison to its peers in the industry, here are the numbers: BSX stock’s performance was 0.85% at last check in today’s session, and 29.05% in the past year. Boston Scientific Corp. has a P/E ratio of 63.44.
An evaluation of the daily trading volume of Boston Scientific Corp. (NYSE:BSX) indicates that the 3-month average is 6.34 million.
Currently, records show that 1.47 billion of the company’s shares remain outstanding. The insiders hold 0.44% of outstanding shares, whereas institutions hold 93.82%. However, since the stock’s price has seen 17.46% year-to-date, investors’ interest is likely to be reignited due to its potential to move even higher.
